World Health Organization report on antimicrobial resistance.

🌍 Antimicrobial Resistance: The Silent Pandemic We Can’t Afford to Ignore While the world has focused heavily on emerging infectious diseases like COVID-19, another global health threat has been steadily rising antimicrobial resistance (AMR). AMR occurs when bacteria, viruses, fungi, and parasites evolve to resist the medicines designed to kill them. This silent pandemic is projected to cause millions of deaths if left unchecked, surpassing cancer as a leading cause of mortality. Beyond lives lost, the economic toll is staggering: routine surgeries, childbirth, and even minor infections could once again become deadly. The drivers of AMR are multifaceted, overuse of antibiotics in healthcare and agriculture, lack of new drug development, weak infection prevention practices, and inequities in global health systems. Tackling it requires cross-sector collaboration, from policymakers and pharmaceutical innovators to healthcare workers and community members. What gives hope is that AMR is not inevitable. Strengthening surveillance systems, investing in rapid diagnostics, promoting responsible antibiotic use, and prioritizing infection prevention and control (IPC) measures are proven pathways to slowing resistance. AMR reminds us that health security is a shared responsibility. We cannot wait for the crisis to escalate we must act collectively, with urgency and innovation, to safeguard the future of global health. 💡 How do you think your sector can contribute to the fight against AMR? #PublicHealth #InfectiousDiseases #AntimicrobialResistance #HealthSecurity #GlobalHealth

Bacteria are rapidly developing resistance to antibiotics, the World Health Organisation (WHO) warned on Monday, with one in six laboratory-confirmed bacterial infections now caused by antibiotic-resistant pathogens. https://lnkd.in/eFCmXKYH #WHO

WHO Warns of Surge in Drug-Resistant Bacterial Infections   The World Health Organization reports that one in six bacterial infections no longer respond to antibiotic treatment, with resistance rising between five and fifteen percent annually since 2018. More than forty percent of E. coli and over fifty-five percent of K. pneumoniae infections are now resistant to standard therapies.   These findings highlight an urgent and growing threat to global health. Without effective treatments, common infections could once again become life-threatening.   Acurx is developing a new class of antibiotics designed to address this crisis through innovative mechanisms that overcome current resistance patterns.   https://lnkd.in/eMt-KtbV   #AntimicrobialResistance #InfectiousDisease #AcurxPharma #ACXP

Bacteria are rapidly developing resistance to antibiotics, the World Health Organisation (WHO) warned on Monday, with one in six laboratory-confirmed bacterial infections now caused by antibiotic-resistant pathogens. https://lnkd.in/epPP6fMS #WHO

Sharp global rise in antibiotic-resistant infections in hospitals, WHO finds Experts describe findings as deeply concerning and predict 70% increase in related deaths by2050. One in six laboratory-confirmed bacterial infections were resistant to antibiotic treatments in 2023, with more than 40% of antibiotics losing potency against common blood, gut, urinary tract and sexually-transmitted infections between 2018 and 2023, records show. The problem was most severe, and worsening, in low and middle-income countries and those with weaker healthcare systems, according to the World Health Organization’s Global Antibiotic Resistance Surveillance report, which gathered data on more than 23 bacterial infections from 104 countries.

Antibiotic resistance is real — and it's alarming. I came across a blood culture result showing Klebsiella spp. resistant to nearly every commonly used antibiotic. From penicillins to carbapenems, fluoroquinolones, aminoglycosides, and even last-line options like tigecycline and colistin — all resistant. This is what multi-drug resistant (MDR) infections look like in real life. It's a growing threat, especially in low-resource settings where diagnostics, stewardship, and access to newer treatments are limited. This isn't just a lab report — it's a wake-up call for stronger policies on antibiotic use, surveillance, infection control, and investment in antimicrobial research. To fellow scientists, clinicians, and policymakers: *we need to act, and fast.* #AntibioticResistance #AMR #BiomedicalScience #GlobalHealth #InfectiousDiseases #Stewardship #PublicHealthCrisis

I really think the use of antibiotics in veterinary medicine needs to be more thought about and reasoned with rather than giving antibiotics 'just in case' or to 'cover all bases' My own grandfather published an article of his firsthand experience with antibiotic resistance nearly 10 years ago now. He is just a lay person with no medical or veterinary qualifications but he nearly lost his leg and his life and now advocates for change. I myself as an RVN have to question the use of antibiotics in my patients and I feel more of my colleagues should be doing the same. We MUST take antibiotic resistance seriously. It is not only harmful to your patients but also harmful to yourself and the world around you.

When Resistance Writes the Report, We Must Rewrite the Response🔥‼️ Two blood cultures. Two pathogens. One terrifying pattern: multidrug resistance is no longer the exception—it’s the norm. From Escherichia coli to Salmonella spp., we’re seeing resistance across nearly every frontline antibiotic class—cephalosporins, penicillins, macrolides, tetracyclines, and more. These aren’t just lab results. They’re clinical red flags, policy failures, and calls to action. This blood culture result is more than a clinical finding. It’s a snapshot of a system under siege. E. coli, resistant to nearly every frontline antibiotic, leaves only a handful of options—many of which are expensive, inaccessible, or reserved for last-line use. In low-resource settings, this isn’t rare. It’s routine. And it’s deadly. As a medical student and campaign architect, I believe we must go beyond awareness. We need rhythmic, speaker-focused advocacy that: - 🎯 Equips clinicians with stewardship tools - 📊 Translates lab data into public urgency - 🧠 Mentors the next generation to lead with science and empathy This isn’t just about bugs and drugs. It’s about legacy, equity, and survival. Let’s build campaigns that don’t just inform—they intervene. Let’s mentor voices that don’t just echo—they mobilize. Let’s design advocacy that doesn’t just trend—it transforms. AMR #AntibioticResistance #OneHealth #MentorshipCulture #GlobalHealth #BiomedicalScience #Stewardship #PublicHealthCrisis #CampaignDesign #LegacyBuilding

Nothing makes you realize the critical situation we are in, and the urgency in needing to spread antimicrobial stewardship and infection control practices through healthcare like looking at susceptibility testing on an agar plate. Correlating what susceptibility looks like on an agar plate for a standard organism versus what MDROs with minimal susceptible antimicrobials looks like is an eye-opener. Just because you cannot see an MDRO does not mean it is not a massive threat to the population. I always get chills when I see these organisms associated with patients.

The alarming speed of AMR. What are going to be regulated? Resisted antimicrobials? Unforeseen policies and immediate antimicrobial preservation measures are required.